A new sensor from Abbott has been developed to track both glucose and ketone levels, potentially flagging the risk of diabetic ketoacidosis. The sensor has received a CE mark, indicating approval for use in certain regions. Reports also mention an FDA warning related to Abbott's FreeStyle Libre, although its connection to the new dual sensor is unclear.